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Abstract. To assess malaria-related prevention and treatment strategies in an urban parish of Kampala, Uganda, a
questionnaire was administered to 339 randomly selected primary caregivers of children 1–10 years of age. Our study
population was relatively stable and well educated, with better access to health services than many in Africa. Ownership
of an insecticide-treated net (ITN) was reported by 11% of households and was predicted only by greater household
wealth (highest quartile versus lowest quartile: odds ratio [OR] 21.8; 95% confidence interval [CI], 2.74–173). Among
women, 5% reported use of an ITN and 11% used intermittent preventive therapy (IPT) during their last pregnancy. Use
of appropriate IPT during pregnancy was predicted only by completion of secondary education or higher (OR, 2.87; 95%
CI, 1.13–7.21). Children of 123 (36%) caregivers had experienced an episode of fever in the past 2 weeks. Of these, 22%
received an anti-malarial that could be considered “adequate” (combination therapy or quinine). Only 1% of febrile
children received adequate treatment at the correct dose within 24 hours of onset of fever. The only independent
predictor of treatment with an adequate anti-malarial was accessing a clinic or hospital as the first source of care. In this
urban area, use of appropriate malaria control measures occurs uncommonly.
INTRODUCTION
Malaria remains a leading cause of morbidity and mortality
in Africa. Recent estimates indicate that the burden of dis-
ease is rising, with the median malaria-specific mortality
among 13 countries in sub-Saharan Africa increasing from 7.8
to 10.2 per 1,000 children over the last 50 years.1 The increase
in disease burden is likely caused by the spread of drug re-
sistance. Interventions shown to reduce malaria-related mor-
bidity and mortality include use of insecticide treated bed nets
(ITNs), use of intermittent preventive treatment (IPT) during
pregnancy, and prompt treatment of clinical cases with effec-
tive anti-malarial drugs. These interventions currently repre-
sent the cornerstones of malaria control in Africa.2 In an
effort to tackle the growing malaria burden, African leaders
attending the Roll Back Malaria summit in Abuja in 2000
committed to improve access to ITNs, IPT, and anti-malarial
treatment. Specifically, they pledged that by 2005, 60% of
those at risk for malaria (particularly children < 5 years of age
and pregnant women) should benefit from protective mea-
sures including ITNs, 60% of all pregnant women at risk of
malaria should have access to IPT, and 60% of malarial illness
should be treated with affordable and appropriate treatment
within 24 hours of onset of symptoms.3
Since the Abuja summit, efforts to increase access to effec-
tive prevention and treatment measures have been made
throughout Africa. However, barriers to full implementation
of control measures exist, including cost and availability of
bed nets and new anti-malarial drugs and awareness and ac-
ceptability of new programs. In addition, defining appropriate
treatment has become increasingly complex in the face of
rising drug resistance and recent changes in anti-malarial drug
policy in Africa. In Uganda, bed nets are currently available
through commercial distributors, with additional delivery of
subsidized ITNs to vulnerable groups such as children and
pregnant women. ITN use in Uganda has been monitored
with standardized national surveys,4 but population-based
data on demographic and socioeconomic factors associated
with ITN use are limited. Efforts to scale up IPT during preg-
nancy began in 2002 with an intensive campaign to train
health care workers and ensure consistent supply of sulfadox-
ine-pyrimethamine (SP).5 However, no data on uptake of this
policy are currently available. Uganda’s anti-malarial drug
policy has also been revised twice in the last 5 years, with the
recommendation for first-line treatment of uncomplicated
malaria changing from chloroquine to chloroquine + sulfa-
doxine-pyrimethamine (CQ+SP) in 2000, and more recently
to artemether-lumefantrine (Coartem).6 Coartem may also
replace CQ+SP in the national home-based management of
fever (HBMF) program, in which pre-packaged anti-malarial
drugs are distributed by trained members of the community
to presumptively treat childhood fever. To date, implemen-
tation of the new policy has been delayed by lack of avail-
ability of Coartem. Little is known about the current practice for
management of malaria at the community level in the setting of
changing approaches to prevention and anti-malarial treatment.
Urbanization also impacts malaria control in Africa. Sub-
Saharan Africa currently has the highest rate of urbanization
in the developing world,7 with an estimated 200 million
people (24.6% of the total African population) living in urban
settings where they are at risk for malaria.8 Rapidly growing
urban communities differ from rural populations in that they
are generally younger, more socioeconomically and culturally
diverse, and have greater access to education and health care
facilities.9 Some studies have shown that use of preventive
measures for malaria and treatment practices for fever may
differ significantly between rural and urban areas, with
greater uptake of bed nets and greater use of private sector
pharmaceuticals in urban settings.10,11 It is likely that inter-
ventions designed for rural settings may not be applicable in
an urban context. Here, we examine current prevention and
treatment practice in an urban area of Kampala, Uganda to
identify predictors of adequate malaria-related prevention
and treatment strategies that may guide future malaria con-
trol efforts in urban settings.
* Address correspondence to Sarah G. Staedke, San Francisco Gen-
eral Hospital, 1001 Potrero, Building 30, Room 408, San Francisco,
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MATERIALS AND METHODS
Description of study site. The study was conducted in Mu-
lago III parish in Kampala, Uganda. This parish is located
near Mulago Hospital, Uganda’s main public hospital and
tertiary referral center. The parish covers an area of slightly
less than 1 km2, with a population density of 18,824 persons/
km2. The local economy is primarily dependent on petty com-
mercial activities and small-scale farming. A large swamp ex-
tends along the northern border of the parish with poor drain-
age and frequent flooding during the rainy seasons. Malaria is
considered meso-endemic in this region, occurring through-
out the year with peaks during two rainy seasons (Ugandan
Ministry of Health, unpublished data). Health facilities within
the parish include nine private clinics offering consultation
services and 16 drug shops (vendors that primarily sell com-
mercially produced pharmaceuticals). Some medications can
also be purchased at other shops and kiosks throughout the
parish. Mulago Hospital is no more than 2 km from any sub-
section of the parish, and two full-service pharmacies are lo-
cated adjacent to the hospital grounds.
Selection of study subjects. From July to October 2004, a
census of Mulago III parish was conducted to provide a sam-
pling frame of households with children 1–10 years of age for
recruitment into a longitudinal study of anti-malarial combi-
nation therapy. The parish was systematically surveyed by
study personnel, and each household was enumerated.
Households were defined as any single permanent or semi-
permanent structure acting as the primary residence for a
person or group of people. After enumeration, study person-
nel asked an adult resident (18 years of age or older) from
each household for verbal consent to participate in a brief
demographic survey including information on number and
age of all residents. A resident of a household was defined as
a person who intended to sleep primarily at that location for
the subsequent 6 months. If no adult resident was available,
households were revisited up to four times to complete the
census. The house was considered vacant if no residents were
present at the household after four visits. Occupied house-
holds were mapped using Pathfinder Pocket Global Position-
ing System (GPS) Receivers (Trimble Navigation, Sunnyvale,
CA) equipped with TerraSync 2.40 software (Trimble Navi-
gation, Sunnyvale, CA) connected to handheld personal digi-
tal assistants (PDAs). A minimum of 12 satellite readings,
taken from the door of the household, were averaged to ob-
tain the final GPS reading (Easting, Northing, and Altitude)
for each household in UTM units.
From a database of all households enumerated in the cen-
sus, a random list of households with at least one child less
than 10 years of age was generated. From November 2004 to
April 2005, home visitors approached households for recruit-
ment sequentially from the randomized list, using handheld
GPS receivers to locate households by previously recorded
coordinates. Households were assessed for the following se-
lection criteria for each eligible child for recruitment into the
longitudinal study of anti-malarial combination therapy: 1)
age 1–10 years; 2) agreement to come to study clinic for any
febrile episode or illness; 3) agreement to avoid medications
administered outside the study; 4) agreement to remain in
Kampala; 5) absence of known chronic disease or history of
side effects to the study medications, and 6) written informed
consent provided by parent or guardian.
Within 2 weeks of screening, a survey was administered at
home to the primary caregiver for each household with at
least one child meeting selection criteria. The primary care-
giver was defined as the household resident claiming primary
responsibility for the daily care of the child(ren) screened.
The study was approved by the Institutional Review Boards
at the University of California, San Francisco and Makerere
University School of Medicine, and by the Ugandan National
Council of Science and Technology.
Household survey. A questionnaire on primary caregiver
and household demographics, socioeconomic characteristics,
household assets, malaria-related prevention measures, and
treatment strategies for childhood fever was developed, based
on standardized survey instruments12–14 and a pilot survey
previously administered in Kampala by our study group.
Caregivers were interviewed in their primary language. Re-
spondents were considered literate if they had completed sec-
ondary school or could read a sentence printed on a card in
either English or Luganda.12 Bed net ownership was con-
firmed by direct observation. Ownership of an ITN was as-
sessed by asking about re-treatment and brand of net and
observing the net purchased. A bed net was considered an
ITN if the net was reported to have been treated with insec-
ticide after purchase or based on the observed brand of the
net. Malaria prevention strategies during pregnancy were as-
sessed by asking female caregivers about measures taken dur-
ing their most recent pregnancy. Knowledge of treatment
strategies for fever was assessed by asking what the caregiver
would do first if his or her child had fever. If giving paracet-
amol was the first response, the caregiver was asked what
she/he would do next if the child did not improve. Illness
histories were taken from any caregiver reporting an episode
of fever in a child under her/his care in the 2 weeks before
screening. If a caregiver reported febrile illness in more than
one child under her/his care, the history of the child most
recently ill was obtained. For each illness episode, details
were documented on symptoms and perceived severity of the
illness, duration, medications given, dosing intervals, where
and at what stage of the illness treatment was sought, and
expenditures on management of the illness. Based on World
Health Organization guidelines for empirical management of
fever, prompt treatment was defined as treatment within 24
hours of illness onset.15
Data management and analysis. Survey data were entered
directly into an electronic data collection system using Visual
CE 8.1 software (Syware, Cambridge, MA) on a handheld
PDA. Home visitors were required to review and confirm the
accuracy of data before completion of the interview. Analysis
was performed using SPSS version 10.0 (SPSS, Chicago, IL)
and STATA version 8.0 (STATA Corp., College Station, TX)
statistical software programs.
Categorical variables were compared using the 2 test or a
non-parametric test for trend and continuous variables using
a two-sample t test or a non-parametric test when appropri-
ate. Infant and child mortality rates were estimated based on
birth histories taken from female primary caregivers.12 Inde-
pendent predictors of positive malaria-related knowledge and
prevention and treatment strategies were identified using
multivariate logistic regression models. Based on current
guidelines in Uganda, knowledge regarding positive treat-
ment strategies was defined as preferred use of any combina-
tion therapy or quinine as a first treatment or a preference for
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taking the child directly to a clinic or hospital before treat-
ment. Adequate treatment practice for fever in the previous 2
weeks was defined as use of a combination therapy or quinine
as the first treatment, regardless of where the treatment was
obtained. Predictor variables retained in all models included
primary caregiver characteristics of age, sex, level of educa-
tion, and number of children under care (or parity when con-
sidering prevention strategies during pregnancy), as well as an
index of household wealth. The household wealth index was
created using principal component analysis (PCA)16,17 of data
on household possessions, utilities, and housing construction.
Households were ranked according to their distribution along
the index, which was divided into quartiles and classified as an
ordinal variable for use in logistic regression models. Addi-
tional variables that were assessed but only retained in the
final models if they were of borderline significance (P  0.10)
included variables related to past experiences of primary
caregivers with the hospitalization or death of children, and
use of a clinic or hospital as the first point of care. In our final
models, P < 0.05 was considered statistically significant.
RESULTS
Of 582 households approached for recruitment into the
study, 243 did not meet selection criteria. The most common
reasons for exclusion of households were no children 1–10
years of age (118/582 [20%]), no provision of informed con-
sent (14%), or household vacated or destroyed (5%). Primary
caregivers from all 339 households that met selection criteria
were successfully interviewed.
Characteristics of primary caregivers and house-
holds. Characteristics of primary caregivers and households
are summarized in Table 1. Most caregivers were women and
were responsible for the care of a median of 3 children (range,
1–16 children). Our study population was diverse in terms of
tribe, religion, and occupation. Nearly one half of caregivers
had completed secondary school, and 82% were literate. A
total of 301/305 (99%) female caregivers reported having
been pregnant, either currently or in the past. Of these, 162
(53%) were pregnant within the last 3 years. The proportion
of women using a bed net during pregnancy increased over
TABLE 1
Primary caregiver and household characteristics (n  339)
Primary caregiver characteristics Household characteristics
Mean age in years (SD, range) 31.4 (9.2, 15–79) Median number of residents (range) 5 (2–15)
Female 305 (90%) Median number of rooms (range) 1 (1–7)
Median no. of children under care 3 (range 1–16) Ownership of home 81 (24%)
Tribe Median monthly rent in USD (range)† $17 ($5–$139)
Baganda 172 (51%) Ownership of land 173 (51%)
Banyorwanda 29 (9%) Source of drinking water
Banyankole 25 (7%) Open spring or well 151 (45%)
Basoga 19 (6%) Closed communal tap 178 (53%)
Batoro 18 (5%) Private tap 9 (3%)
Bakiga 16 (5%) Toilet facility
Other 60 (18%) Uncovered pit latrine 212 (63%)
Religion Covered pit latrine 70 (21%)
Protestant 110 (32%) Ventilated pit latrine 39 (12%)
Catholic 109 (32%) Flush toilet 16 (5%)
Muslim 73 (22%) None 2 (1%)
Other 47 (14%) House structure‡
Highest educational level completed Cement floor 292 (86%)
None 16 (5%) Cement walls 283 (83%)
Primary schooling 160 (47%) Metal roof 333 (98%)
Secondary schooling 154 (45%) Electricity in home 200 (59%)
University 9 (3%) Household possessions‡
Literate* 276 (82%) Radio 267 (79%)
Job Telephone 178 (53%)
Unemployed 105 (31%) Television 133 (39%)
Sales and services 153 (45%) Refrigerator 38 (11%)
Skilled or unskilled manual labor 35 (10%) Motorcycle 20 (6%)
Other 46 (14%) Ownership of at least one bednet 208 (61%)
Continuously employed 187 (55%) Ownership of at least one ITN 37 (11%)
Residency in Kampala Use of other prevention measures‡
Entire life 143 (42%) Sprays/coils 100 (30%)
Greater than 10 years 70 (21%) Closing doors/windows at night 68 (20%)
5–10 years 79 (23%) Covering water sources 26 (8%)
Less than 5 years 47 (14%) Any chemoprophylaxis 8 (2%)
Mesh window screens 2 (1%)
Malaria prevention during pregnancy§
Before 1995 (n  38) 1995–2001 (n  101) 2002 or later (n  162)
Use of any bednet 3 (8%) 30 (30%) 107 (66%)
Use of an ITN 0 (0%) 3 (3%) 13 (8%)
Appropriate IPT¶ 1 (3%) 8 (8%) 23 (14%)
* Literacy defined as those who attended at least secondary school or can read a whole sentence.
† Exchange rate 1750 Uganda shillings  $1 US dollar.
‡ Not mutually exclusive.
§ Includes 301 women (21 currently pregnant and 280 previously pregnant women considering last pregnancy).
¶ Defined as two doses of sulfadoxine-pyrimethamine, one each during second and third trimester.
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time, from 8% before 1995, to 30% in 1995–2001, and to 67%
in 2002–2005 (P < 0.001). Use of appropriate IPT in preg-
nancy, defined according to current guidelines as two doses of
SP, taken during the second and third trimester, changed less
dramatically (3% before 1995, 8% in 1995–2001, 14% in
2002–2005; P  0.02). Infant and child mortality rates in our
population over a 5-year period from 2000 to 2004 were es-
timated as 46.8 and 15.5 per 1,000 live births, respectively.
Households were typically composed of a single room, with
a median of five residents per household. For households that
did not own their home, median monthly rent was US$17.
Ownership of at least one bed net was reported and con-
firmed by direct observation in 61% of households. However,
only 11% of households owned an ITN, and of these, 31%
reported they had not re-treated their net within the last 6
months. Fifty percent of households reported using preven-
tion measures other than bed nets, including use of sprays or
coils, closing doors, or windows at night, covering water
sources, taking chemoprophylactic anti-malarial medications,
or using mesh screens on windows.
Factors associated with prevention strategies. Multivariate
logistic regression analysis was used to assess independent
predictors of use of prevention strategies (Table 2). Younger
caregivers and caregivers who had completed secondary edu-
cation or higher were more likely to live in households with
bed nets. Households falling into progressively higher quar-
tiles of the wealth index were also increasingly likely to own
bed nets. Household ITN ownership, however, was predicted
only by greater household wealth (third quartile versus first
quartile: OR, 8.1; 95% CI, 0.99–67; fourth quartile versus first
quartile: OR, 21.8; 95% CI, 2.74–173). Among female care-
givers, the strongest predictor of bed net use during preg-
nancy was the time at which the pregnancy occurred, with
more recent pregnancy predicting use of a bed net. Use of
appropriate IPT during pregnancy was predicted only by
completion of secondary education or higher (OR, 2.87; 95%
CI, 1.13–7.21). In contrast to bed net ownership, use of pre-
vention strategies during pregnancy (bed nets or IPT) was not
significantly associated with household wealth.
Experience of primary caregivers with health facilities. Our
population of primary caregivers reported having used both
private and public health facilities in the past: 52% had ex-
perienced hospitalization of a child under their care, 99% had
taken a child to a clinic or hospital, and 84% had bought
medicines from a drug shop or pharmacy. A total of 27% of
caregivers reported that a child under their care had died.
When asked about problems experienced accessing care at
clinics or hospitals, the most frequent responses were: long
wait time (34%), too expensive (27%), or problems with
drugs (i.e., no drugs available, wrong drugs given, or the drugs
were expired; 23%). Of those who had accessed drugs shops
or pharmacies, the most common problems were that the
drugs were too expensive (35%) and that the desired drugs
were not available or were expired (14%).
Knowledge of treatment strategies. When primary caregiv-
ers were asked which strategy they preferred for initial man-
agement of fever in their child, the most common responses
were give chloroquine or paracetamol followed by chloro-
quine (48%), take the child directly to a clinic or hospital for
treatment (34%), and give quinine (5%). Fourteen of 339
TABLE 2
Multivariate predictors of positive malaria-related prevention strategies
Predictor variables*
Household prevention strategies (n  339)
Own at least one bednet Own at least one ITN
OR (95% CI) P value OR (95% CI) P value
Age† 0.86 (0.75–1.00) 0.04 0.95 (0.75–1.22) 0.71
Female 1.97 (0.89–4.36) 0.10 0.86 (0.28–2.68) 0.80
Education level‡ 2.24 (1.35–3.73) 0.002 1.69 (0.73–3.90) 0.22
No. of children under care 0.91 (0.81–1.03) 0.13 1.14 (0.98–1.33) 0.08
Household asset index
< 25th percentile 1.0 – 1.0 –
25th to 50th percentile 1.39 (0.73–2.63) 0.31 3.70 (0.40–34.2) 0.25
50th to 75th percentile 2.22 (1.14–4.31) 0.02 8.14 (0.99–67.0) 0.05
> 75th percentile 3.51 (1.66–7.39) 0.001 21.8 (2.74–173) 0.004
Predictor variables*
Prevention strategies during pregnancy (n  300)§
Use of bednet Use of IPT
OR (95% CI) P value OR (94% CI) P value
Age at last pregnancy† 1.10 (0.80–1.53) 0.56 1.42 (0.91–2.22) 0.12
Year of pregnancy
Before 1995 1.0 1.0
1995–2001 7.22 (1.60–32.5) 0.01 2.18 (0.25–18.8) 0.48
2002 or later 35.1 (7.89–156) <0.001 4.03 (0.50–32.3) 0.19
Education level‡ 1.68 (0.95–2.98) 0.08 2.87 (1.14–7.21) 0.03
Parity 0.98 (0.81–1.18) 0.84 0.75 (0.55–1.01) 0.06
Household asset index
< 25th percentile 1.0 – 1.0 –
25th to 50th percentile 1.12 (0.53–2.35) 0.77 1.04 (0.29–3.65) 0.96
50th to 75th percentile 1.19 (0.56–2.52) 0.65 1.15 (0.33–3.98) 0.83
> 75th percentile 1.66 (0.73–3.74) 0.33 1.35 (0.39–4.64) 0.63
* Characteristics of the primary caregiver (with the exception of household asset index).
† Per 5 year increase.
‡ Secondary school or higher versus primary school or none.
§ One caregiver with missing parity data excluded from analysis.
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(4%) caregivers stated that they would give an anti-malarial
combination therapy (CQ+SP, AQ+SP, or quinine + another
anti-malarial). Younger caregivers and caregivers who had
never had a child hospitalized in the past were significantly
more likely to name a positive strategy in response to fever,
defined as quinine, combination therapy, or taking the child
to a clinic or hospital (Table 3). Only 17% of caregivers cor-
rectly identified the government-recommended first-line
treatment of uncomplicated malaria (CQ+SP). Other com-
mon responses included don’t know (36%), chloroquine
(17%), and SP (11%). None of the predictors in our model
were associated with knowledge of government-recom-
mended therapy (Table 3).
Actions taken for fever in the previous 2 weeks. Treatment
source and costs. Of 339 primary caregivers interviewed, 132
(39%) reported an episode of fever in a child under their care
in the preceding 2 weeks. The median duration of the illness
was 4–7 days, and primary caregivers spent a median of 2 days
caring for their child rather than performing their usual ac-
tivities (range, 0–21 days). The sequence of actions taken by
primary caregivers in response to fever is outlined in Figure 1.
Almost all episodes (98%) were treated, and commercially
produced pharmaceuticals were used in 97% of cases. Only
one caregiver reported using herbs, and no caregivers re-
ported visiting a traditional healer. Most caregivers sought
treatment outside the home as their first course of action
(89%). Of those who first sought treatment outside the home,
96% obtained treatment in the private sector (61% bought
medicines at a private vendor, defined as a general shop, drug
shop, or pharmacy, and 35% took the child to a private clinic).
Only five (4%) caregivers took their child to a public hospital.
Caregivers who perceived their child’s illness as severe were
more likely than those who did not to take their child to a
clinic or hospital as their first action (47% versus 20%, P 
0.001) and were more likely to obtain adequate treatment of
their child (31% versus 12%, P 0.009). However, caregiver
perception of severity did not significantly impact on prompt-
ness of treatment. Treatment within 24 hours was sought by
17% of caregivers who thought their child’s illness was severe
versus 29% of those who did not (P  0.12).
In 47 (36%) cases, the child failed to improve after the first
action, and the caregiver went on to take a second action.
Second actions were more frequent among those who first
treated the child at home (50%) or who bought medicines
from a private vendor (42%) than among those who first took
their child to a private clinic (27%). None of the children first
taken to a public hospital were subsequently treated at an-
other source. Considering both first and second actions, 51%
of children received care at a clinic or hospital. The median
expenditure on management of febrile illness was US$1.43
(range, $0–$27). Summing costs across all episodes, US$0.79
of each dollar spent went to medicines, $0.05 to clinic fees,
$0.08 to transport, and $0.08 to special food and drink re-
quired by the sick child. The median expenditure for those
who first sought treatment at a clinic or hospital (US$4.00;
range, 0–US$27) was significantly higher than for those who
TABLE 3
Multivariate predictors of positive knowledge and practice of treatment for malaria
Predictor variables*
Knowledge of treatment strategies for fever in children (n  339)
Knowledge of positive treatment strategy†
Knowledge of government recommended
first-line drug‡
OR (95% CI) P value OR (95% CI) P value
Age§ 0.79 (0.68–0.92) 0.002 1.03 (0.86–1.22) 0.78
Female 1.91 (0.84–4.33) 0.12 0.55 (0.23–1.30) 0.17
Education level¶ 0.88 (0.54–1.44) 0.61 1.21 (0.64–2.29) 0.57
No. of children under care 0.97 (0.86–1.09) 0.56 0.89 (0.76–1.05) 0.18
Hospitalized child** 0.60 (0.38–0.96) 0.03 1.12 (0.61–2.04) 0.72
Household asset index
< 25th percentile 1.0 – 1.0 –
25th to 50th percentile 0.54 (0.28–1.04) 0.07 0.71 (0.30–1.70) 0.45
50th to 75th percentile 1.10 (0.57–2.09) 0.78 1.08 (0.47–2.46) 0.86
> 75th percentile 1.44 (0.72–2.88) 0.30 1.08 (0.46–2.56) 0.86
Predictor variables*
First medicines given for fever in the previous 2 weeks (n  123)
Any antimalarial drug†† Adequate therapy‡‡
OR (95% CI) P value OR (95% CI) P value
Age§ 1.12 (0.83–1.51) 0.47 1.00 (0.70–1.42) 0.99
Female 1.38 (0.26–7.21) 0.70 1.00 (0.12–8.52) 1.00
Education level¶ 1.17 (0.46–3.00) 0.75 0.50 (0.12–2.00) 0.32
No. of children under care 1.16 (0.93–1.45) 0.19 1.03 (0.76–1.41) 0.84
Household asset index
< 25th percentile 1.0 – 1.0 –
25th to 50th percentile 1.48 (0.47–4.63) 0.50 1.28 (0.22–7.24) 0.78
50th to 75th percentile 2.92 (0.85–10.04) 0.09 4.73 (0.76–29.34) 0.10
> 75th percentile 1.01 (0.25–4.16) 0.99 2.69 (0.35–20.48) 0.34
Clinic as first point of care 19.5 (4.19–90.82) <0.001 40.9 (10.3–162.6) <0.001
* Characteristics of the primary caregiver (except household asset index and clinic as first point of care).
† Positive treatment strategy as combination therapy, quinine, or going directly to clinic/hospital.
‡ Chloroquine + sulfadoxine-pyrimethamine (CQ + SP) at the time of this study.
§ Per 5-year increase.
¶ Secondary school or higher vs primary school or none.
** A child under the care of primary caregiver has been hospitalized in the past.
†† Antimalarial drugs defined as CQ, SP, amodiaquine (AQ), quinine, artemisinin, or combination of these.
‡‡ Adequate therapy defined as quinine, CQ + SP, AQ + SP, or quinine + another antimalarial.
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treated at home or bought medicines from a drug shop
(US$0.83; range, 0–US$15; P < 0.001).
Drugs used and factors associated with adequate treatment.
Drugs given with the first action are summarized in Figure 2.
Medicines unknown to the primary caregiver were given in 9
(7%) cases, all but one of which was obtained at a clinic or
hospital. Including only episodes in which the primary care-
giver knew what medicines were given (N  123), 68% of
febrile episodes were treated with an anti-malarial medica-
tion. Of these, 45% received a correct dose. The most com-
mon first medication given for fever was chloroquine (34%),
followed by paracetamol (25%). The first action included
treatment with an antibiotic in only 11% of cases. Adequate
anti-malarials, defined as combination therapy or quinine, ac-
counted for 22% of known treatments, of which 15% were
administered in the correct dose. Of the 27 children given an
adequate anti-malarial, 6 (22%) went on to seek a second
action compared with 39/96 (41%) of those who were not
initially treated with an adequate anti-malarial (P  0.08).
Treatment with CQ+SP, the current government recom-
mended first-line therapy, accounted for only 8% of first ac-
tions. Treatment with an adequate anti-malarial was signifi-
cantly more likely when the child was taken to a clinic or
hospital than when the caregiver treated the child at home or
bought medicines from a private vendor (61% versus 5%, P <
0.001). By multivariate analysis, accessing a clinic or hospital
as the first source of care was the only independent predictor
of treatment with an anti-malarial drug or of treatment with
an adequate anti-malarial (Table 3).
Promptness of treatment and time to anti-malarial treat-
ment. Seventy percent of caregivers reported no delay in
seeking treatment. However, only 21% of caregivers obtained
any treatment of their child within 24 hours. Children first
treated at home or with medicines from a private vendor were
no more likely to receive prompt treatment with an anti-
malarial than those taken directly to a clinic or hospital (13%
versus 21%, P  0.27). The median time to anti-malarial
treatment was 1–3 days after onset of fever, with 19% treated
within 24 hours, 65% treated within 1–3 days from onset of
fever, 14% within 4–7 days, and 2% after > 7 days. Overall, 19
of 123 fevers (15%) were treated with an anti-malarial within
24 hours. However, only six (5%) treatments included prompt
treatment with an adequate anti-malarial, and only one (1%)
included prompt treatment with an adequate anti-malarial
given in the correct dose.
DISCUSSION
In this study, we investigated malaria-related prevention
and treatment practices in an urban African setting. We
found that few households owned ITNs, and only 8% of
women reported using an ITN during pregnancy within the
last 3 years. Household wealth was strongly associated with
bed net and ITN ownership, but did not seem to predict use
of prevention measures during pregnancy. Services outside of
the formal health sector were used commonly, with many
caregivers obtaining treatment from private vendors. Nota-
FIGURE 1. First and second actions taken by primary caregivers reporting a child with fever in the previous 2 weeks. Private vendors include
general shops, drug shops, and pharmacies. Non–anti-malarials include paracetamol, aspirin, antihistamines, vitamins, herbs, and non–anti-
malarial antibiotics. Inadequate anti-malarial defined as chloroquine (CQ), sulfadoxine-pyrimethamine (SP), or amodiaquine (AQ) monotherapy.
Adequate anti-malarial defined as quinine monotherapy or combination therapy (CQ+SP, AQ+SP, quinine + another anti-malarial).
FIGURE 2. Medications given as first action in response to fever
(N  132). CQ, chloroquine; AQ, amodiaquine; SP, sulfadoxine-
pyrimethamine.
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bly, we found that prompt treatment with adequate anti-
malarial drugs occurred rarely. Despite recent changes in
drug policy in Uganda and the availability of a variety of
anti-malarial drugs in Kampala, chloroquine remained the
most common treatment of childhood fever. Only 5% of fe-
vers were treated with an adequate anti-malarial regimen
within 24 hours of illness onset. Adequate treatment was
more likely to be obtained from a clinic or hospital; treatment
given at home or obtained from a private vendor was fre-
quently inadequate. Even in this urban area, with close prox-
imity to an array of health services, we are still far from
meeting the malaria control targets set by African leaders at
Abuja in 2000.
One of the strengths of this study was the use of probability
sampling to generate a representative group of primary care-
givers from our target population. In general, our study site is
likely to differ from other urban areas as it is located within
Uganda’s largest and most developed city. Comparing the
demographics of our study population to urban populations
described in the Uganda Demographic and Health Survey
(DHS) conducted in 2000–2001, there were notable differ-
ences. Child mortality rates were considerably lower in our
population (15.5% versus 48.7%).4 The proportion of pri-
mary caregivers completing at least secondary school was
comparable with that reported for urban Ugandan women;
however, literacy was slightly higher (82% versus 76%).
Based on a number of factors (including employment, access
to electricity, quality of housing material, and ownership of
mobile phones), our study population was somewhat more
wealthy than other urban households. In addition, our study
population had much greater access to education and ameni-
ties than the majority of the Ugandan population living in
rural areas.4
Bed net ownership was relatively common in our study
population, but use of ITNs and IPT was far below target
levels. Compared with other urban households, twice as many
households in our population owned bed nets (61% versus
33%) and use of bed nets during pregnancy was five times
higher among women reporting pregnancies in the last three
years (66% versus 13%).4 However, despite unexpectedly
high levels of bed net ownership, use of ITNs remained low
(11% of households and 8% of pregnant women), consistent
with other observations in sub-Saharan Africa.11 In addition,
use of any IPT (including CQ and/or SP) during pregnancy in
our study population was less common than previously re-
ported for urban populations in Uganda, even after the imple-
mentation of the national IPT program in 2002 (25% versus
38%). However, among women using IPT in the last 3 years,
SP dosed once in the second trimester and once in third tri-
mester accounted for a larger proportion of all IPT in our
population than in the DHS (56% versus 4%), possibly re-
flecting the recent changes in IPT recommendations.
In our multivariate analysis, we evaluated for predictors
associated with use of malaria prevention measures. We
found that younger age, higher education level, and increased
household wealth were associated with ownership of bed nets,
but that only wealth, as measured by our household wealth
index, predicted ownership of ITNs. An association between
wealth and bed net ownership has been previously docu-
mented.18–22 This is not unexpected, given that the cost of a
single ITN may approximate 1 week’s wages for some house-
holds.22 The association between bed net ownership and
higher education has also been shown elsewhere.18,22 Inter-
estingly, wealth was not a predictor of use of prevention mea-
sures during pregnancy. The year of pregnancy was the
strongest predictor of bed net use in pregnancy, whereas
higher education level was the only independent predictor of
use of IPT. Not surprisingly, use of bed nets and IPT during
pregnancy was more common in recent years, corresponding
to efforts to scale-up ITNs and IPT in Uganda.
Prompt treatment of malaria with effective anti-malarials is
one of the key strategies for malaria control in Africa. Be-
cause barriers to obtaining care within the formal health sec-
tor may be substantial and laboratory-confirmed diagnoses
are often lacking, presumptive treatment of febrile children
with anti-malarials has been widely advocated in malaria-
endemic areas.15 In Africa, treatment of fever at home is
common, either as primary management of fever or before
seeking care from a health facility, frequently using drugs
purchased from private vendors.10,23–26 Our results confirm
the importance of private vendors as an initial source of care
for childhood fever in Kampala, with 55% of all febrile epi-
sodes treated initially with drugs bought at a shop or phar-
macy. Use of anti-malarials as first-line treatment of child-
hood fever in our population (68%) was similar (or higher) to
that reported from other urban settings in Ghana, Malawi,
and Uganda.27–29 However, we found that defining appropri-
ate therapy was challenging, given rapidly changing recom-
mendations for first-line treatment of malaria and widespread
drug resistance. This was not an issue in previous studies,
conducted when chloroquine was still considered the drug of
choice for uncomplicated malaria. Recently, studies from
Kenya and Malawi, which studied treatment practices after
change in national drug policy from chloroquine to SP, found
a gap between the proportion of fevers treated with any anti-
malarial and those treated with the recommended regi-
men.28,30 In our study, only 32% of anti-malarial treatments
given for initial management of fever in children were con-
sidered adequate. CQ+SP, the recommended first-line
therapy adopted in 2002, was poorly used, accounting for only
13% of anti-malarial treatments. Although a wide variety of
anti-malarials are available in Kampala, we found that chlo-
roquine remained the most commonly used drug for fever,
with chloroquine monotherapy accounting for 54% of treat-
ments. Combination regimens other than CQ + SP were used
rarely. As drug policies evolve and more anti-malarial drugs
become available, the gap between policy and practice is
likely to widen.
Prompt treatment with adequate anti-malarials, defined by
the WHO as treatment administered within 24 hours of the
onset of illness, occurred rarely in our population. Initial
treatment was most commonly given 1–3 days after the onset
of fever. Only 15% of febrile episodes were treated with an
anti-malarial drug within 24 hours, and only 5% were treated
with an adequate regimen within 24 hours. Caregivers in our
population were no more likely to obtain prompt anti-
malarial treatment of their child if they first sought care out-
side the formal health sector than if they first took their child
to a clinic or hospital. This is in contrast to findings from rural
Africa, where distance to health care facilities likely has a
significant impact on access to care.31,32 Although the time
from initial presentation to development of severe malaria or
death may be short,24,33–36 the evidence base for recommend-
ing treatment of fevers within 24 hours is limited, and the role
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that time to treatment plays in determining disease outcome
remains unclear. In our study, many caregivers did not per-
ceive waiting for over 24 hours before seeking treatment as a
delay. If the goal of achieving prompt treatment is to be met,
this perception will need to be changed.
Our results showed a significant difference in the likelihood
of adequate treatment based on the first source of care. Care-
givers who first sought care at a clinic or hospital were much
more likely to obtain adequate treatment of their child than
those who sought care outside the formal health sector (61%
versus 5%). In our multivariate model, seeking care first at a
clinic or hospital was the only independent predictor of ad-
equate treatment. Treatment obtained from private vendors
was no more likely to be adequate than treatment given at
home by the caregiver. These data suggest that, in a setting
where most treatments are obtained outside of the formal
health sector, it may be difficult to provide appropriate anti-
malarial therapy. Promoting health facility–based treatment
in urban areas is an option, although this approach poses
several challenges. In our study, the cost of care obtained
from a clinic or hospital was four times as expensive as that of
other alternatives and may be far more expensive than home-
based approaches. However, we also found that wealth was
not associated with adequate treatment in our multivariate
analysis, suggesting that cost may not deter caregivers from
obtaining appropriate treatment. Additional barriers to for-
mal health facility care, including long waiting times, drug
availability, and poor prescribing behaviors, must also be ad-
dressed. Alternatively, drug-dispensing practices at private
vendors could be strengthened through regulation or by pro-
viding additional training to shop attendants, an approach
that has been shown to be successful in rural Kenya.37
This study had several potential limitations. We assessed
treatment of malaria based on reports by caregivers, which
could be subject to recall bias. Caregivers may also have been
misinformed as to what medicines they received at private
vendors or formal health facilities. Comparing data collected
during our census with our experience during subject recruit-
ment, we found Mulago III parish to be a highly mobile urban
population, with residents frequently moving within Kampala
or to rural areas. Our sample could have been biased toward
households with more permanent living arrangements. De-
spite these potential limitations, our results are fairly consis-
tent with data from other studies done in urban African set-
tings, suggesting that our sample was representative of this
large and growing segment of the population.
Malaria control targets are not being met in our study
population, a relatively well-educated urban community in
Uganda with easily accessible health care services. In particu-
lar, prompt treatment of febrile illness with appropriate anti-
malarials was seldom accomplished. Our results suggest po-
tential approaches to improving current practices. Strategies
to make bed nets and ITNs more affordable and education
emphasizing the value of prevention practices may improve
appropriate use of ITNs and IPT. Encouraging health facili-
ty–based care, or alternatively, building capacity for delivery
of treatment through private vendors, could optimize prompt,
effective anti-malarial treatment. Well-designed randomized
trials comparing home-based versus clinic-based management
of fever, in both urban and rural settings, should provide
valuable insight into the effectiveness of these strategies.
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